Management of Hypertension with ayurvedic Medicine

Comparative study to evaluate the effect of Rudraksh Elaeocarpus ganitrus Roxb and Sarpagandha Rauvolfia serpentina in the management of stage I essential Hypertension

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029788

Enrollment

Registered

2020-12-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Rudraksha ghana vati: contain Rudraksha will be given in dose of 500 mg twice a day with lukewarm water after meal Control Intervention1: Sarpagandha Ghana vati: Contain sarpagandha wil

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 30 to 60 years irrespective of sex Stage I essential Hypertension Systolic pressure 130 to 139 mmHg and or Diastolic pressure 80 to 89 mmHg on measuring blood pressure with Mercury sphygmomanometer on three different occasions in a day Stage I essential Hypertension with controlled Diabetes mellitus

Exclusion criteria

Exclusion criteria: Hypertensive crisis Systolic over 180 and or diastolic over 120 Hypertension with Cardio vascular diseases Cerebro vascular diseases Hypothyroidism Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
lowers the blood pressureTimepoint: 30 days	—

Secondary

Measure	Time frame
Founding new drug Intervention effective in Hypertension by using Rudraksh churnakriya Timepoint: 30 days	—

Countries

India

Contacts

Public ContactRani Ashokrao Mude

Datta Meghe Institute of Medical Sciences wardha

vkuchewar@gmail.com9420998747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026